IL107153A - Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture - Google Patents

Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture

Info

Publication number
IL107153A
IL107153A IL10715393A IL10715393A IL107153A IL 107153 A IL107153 A IL 107153A IL 10715393 A IL10715393 A IL 10715393A IL 10715393 A IL10715393 A IL 10715393A IL 107153 A IL107153 A IL 107153A
Authority
IL
Israel
Prior art keywords
diabetes mellitus
manufacture
dependent diabetes
pharmaceutical compositions
preventing insulin
Prior art date
Application number
IL10715393A
Other languages
English (en)
Other versions
IL107153A0 (en
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of IL107153A0 publication Critical patent/IL107153A0/xx
Publication of IL107153A publication Critical patent/IL107153A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL10715393A 1992-10-01 1993-09-29 Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture IL107153A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01

Publications (2)

Publication Number Publication Date
IL107153A0 IL107153A0 (en) 1993-12-28
IL107153A true IL107153A (en) 2000-07-16

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10715393A IL107153A (en) 1992-10-01 1993-09-29 Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture

Country Status (23)

Country Link
EP (1) EP0662837B1 (de)
JP (1) JP2739770B2 (de)
KR (1) KR0166663B1 (de)
CN (1) CN1093598A (de)
AT (1) ATE180168T1 (de)
AU (1) AU689448B2 (de)
CA (1) CA2145863A1 (de)
CZ (1) CZ286866B6 (de)
DE (1) DE69325029T2 (de)
DK (1) DK0662837T3 (de)
ES (1) ES2131122T3 (de)
FI (1) FI951511A0 (de)
GR (1) GR3030269T3 (de)
HU (1) HU217871B (de)
IL (1) IL107153A (de)
MX (1) MX9306043A (de)
MY (1) MY111543A (de)
NO (1) NO951240L (de)
SG (1) SG48733A1 (de)
SK (1) SK281806B6 (de)
TW (1) TW336172B (de)
WO (1) WO1994008606A1 (de)
ZA (1) ZA937244B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695883B2 (en) * 1994-04-08 1998-08-27 Brigham And Women's Hospital Treatment of autoimmune disease using oral tolerization and/or Th2-enhancing cytokines
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
DE69534265T2 (de) * 1994-12-12 2006-05-04 Beth Israel Deaconess Medical Center, Inc., Boston Chimäre zytokine und ihre verwendung
JPH11510185A (ja) * 1995-08-07 1999-09-07 シェーリング コーポレイション インターロイキン−１０を用いた眼の炎症性状態の処置
CA2228379A1 (en) * 1995-08-09 1997-02-20 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
US5939069A (en) * 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
AU8671798A (en) * 1997-07-30 1999-02-22 Betagene, Inc. Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
ATE293603T1 (de) * 1997-10-14 2005-05-15 Mitsubishi Pharma Corp Piperazin-verbindungen und ihre medizinische verwendung
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
JP6403062B2 (ja) * 2012-12-21 2018-10-10 国立大学法人徳島大学 組織修復活性組成物及びその利用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
US11510966B2 (en) 2016-04-15 2022-11-29 Evive Biotechnology (Shanghai) Ltd Use of IL-22 in treating necrotizing enterocolitis
EP4106794A4 (de) 2020-02-19 2024-03-20 Evive Biotechnology (Shanghai) Ltd Verfahren zum behandeln der transplant-und-wirts-krankheit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
SG48733A1 (en) 1998-05-18
MY111543A (en) 2000-08-30
FI951511L (fi) 1995-03-30
HK1008812A1 (en) 1999-05-21
NO951240D0 (no) 1995-03-30
SK42395A3 (en) 1997-01-08
AU5163593A (en) 1994-05-09
DE69325029T2 (de) 1999-10-07
CZ286866B6 (en) 2000-07-12
ATE180168T1 (de) 1999-06-15
GR3030269T3 (en) 1999-08-31
DE69325029D1 (de) 1999-06-24
HU9500933D0 (en) 1995-05-29
HUT71421A (en) 1995-11-28
HU217871B (hu) 2000-04-28
CN1093598A (zh) 1994-10-19
AU689448B2 (en) 1998-04-02
SK281806B6 (sk) 2001-08-06
ZA937244B (en) 1994-06-27
KR0166663B1 (en) 1999-01-15
TW336172B (en) 1998-07-11
DK0662837T3 (da) 1999-11-08
CZ80495A3 (en) 1996-01-17
FI951511A7 (fi) 1995-03-30
EP0662837B1 (de) 1999-05-19
EP0662837A1 (de) 1995-07-19
CA2145863A1 (en) 1994-04-28
FI951511A0 (fi) 1995-03-30
NO951240L (no) 1995-05-30
IL107153A0 (en) 1993-12-28
MX9306043A (es) 1994-04-29
JP2739770B2 (ja) 1998-04-15
ES2131122T3 (es) 1999-07-16
KR950703353A (ko) 1995-09-20
JPH07507567A (ja) 1995-08-24
WO1994008606A1 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
IL107153A (en) Pharmaceutical compositions for preventing insulin-dependent diabetes mellitus comprising IL10 and method for their manufacture
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
AU4861493A (en) Clear leave-on treatment composition and method
AU4205789A (en) Method and composition for the treatment and prevention of viral infections
AU4859793A (en) Sulfated ligands for l-selectins and use of chlorates and or sulfatases for the treatment of inflammation
AU4534593A (en) Compositions and methods for enhanced drug delivery
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
EP0717592A4 (de) Verfahren und zusammensetzung zur behandlung des apathie-demotivations-syndroms
CZ44195A3 (en) Pharmaceutical preparation containing il-4 and/or il-10 or antibodies against il-4 and il-10, process of its preparation and use
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU2187992A (en) Composition and method for disease treatment
AU8138687A (en) Agents for combating pests and plant treatment agents
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
AU4896090A (en) Insecticide treatment and compositions therefor
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU564439B2 (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
AU6160594A (en) Diabetes prevention and treatment
AU6494690A (en) Method for the prevention and treatment of bovine mastitis
AU1432292A (en) Drug delivery composition and method of using the same
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
AU7770991A (en) Method and composition for the treatment of cancer
IL105061A (en) Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
IL105285A0 (en) Compositions for the treatment of diabetes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force